Allogene Therapeutics (NASDAQ:ALLO) Price Target Lowered to $7.00 at Piper Sandler
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) had its price target decreased by Piper Sandler from $9.00 to $7.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. ALLO has been the subject of a number of other reports. Robert W. Baird decreased their target price on […]
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) had its price target decreased by Piper Sandler from $9.00 to $7.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. ALLO has been the subject of a number of other reports. Robert W. Baird decreased their target price on […]
